The problem is the years of inactivity waiting for the SML. Now management pushing timelines out further.
This is a honey pot for short term traders (which tend to drive prices), to push the price lower, after consolidation.
Have a look at ARX (health sector) but generating real revenues and not attracting attention from the market. Well undervalued compared to peers. Listed, pumped after the IPO, then the IPO traders sold and been undervalued, for many months (Covid did affect performance last year, but sales have recovered well).
Think we can expect a similar result if PEK consolidates - if they don't have a solid timeline laid out, before they consolidate.
Not investment advice. DYOR
- Forums
- ASX - By Stock
- PEK
- Ann: BFS Update and Target Production Capacity Increase
Ann: BFS Update and Target Production Capacity Increase, page-43
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PEK (ASX) to my watchlist
|
|||||
Last
19.5¢ |
Change
0.005(2.63%) |
Mkt cap ! $51.85M |
Open | High | Low | Value | Volume |
18.5¢ | 20.0¢ | 18.5¢ | $20.94K | 107.9K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 34127 | 19.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
20.0¢ | 53144 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 34127 | 0.195 |
1 | 100000 | 0.190 |
2 | 4702 | 0.185 |
4 | 118360 | 0.180 |
8 | 774907 | 0.175 |
Price($) | Vol. | No. |
---|---|---|
0.195 | 9756 | 1 |
0.200 | 53144 | 2 |
0.205 | 3417 | 1 |
0.210 | 19297 | 1 |
0.220 | 18500 | 1 |
Last trade - 16.10pm 02/07/2024 (20 minute delay) ? |
Featured News
PEK (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham, CEO
James Graham
CEO
SPONSORED BY The Market Online